The original contributions presented in this study are included in the article, further inquiries can be directed to the corresponding authors. Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN ...
Understanding and predicting fatigue, cardiovascular (CV) decline, and events after breast cancer treatment (UPBEAT): A prospective cardio-oncology study. Background: The opioid dose for an individual ...
REDWOOD CITY, Calif., Aug. 23, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative ...
Efficacy of sequencing of cytotoxic and endocrine therapies in veterans with metastatic castration-resistant prostate cancer (mCRPC). This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting ...